|
A Phase 3, Multicenter, Randomized, Double-blind Trial of Brexpiprazole as Combination Therapy with Sertraline in the Treatment of Adults with Post-traumatic Stress Disorder. Protocol No. 331-201-00071
|
|
U20-082-2
|
|
A Phase 3, Multicenter, Randomized, Double-blind Trial of Brexpiprazole as Combination Therapy with Sertraline in the Treatment of Adults with Post-traumatic Stress Disorder. Protocol No. 331-201-00071
|
|
Dr. Jayesh Kamath
|
|
This clinical research trial will study adults who have experienced or witnessed a traumatic event within the past 9 years and have unwanted symptoms as a consequence of that traumatic event. An investigational drug is being studied with another medication for the treatment of post-traumatic stress disorder (PTSD). Total participation is approximately 4 months. This includes a screening phase, a double-blind treatment phase, and a follow-up phase. All study-related visits, tests, and drugs will be provided at no cost. In addition, reimbursement for study-related travel may be provided.
|
Psychiatry - General Adult/Mental Health (Depression, Anxiety, Etc.)
|
|
|
Adults 18 to 65 years of age; have been diagnosed with PTSD symptoms for at least 6 months prior to this study; for additional eligibility criteria, check with study contact
|
|
Galina Prpich. Telephone: 860-679-7539 Email: prpich@uchc.edu
|
|
Enrolling/recruiting
|
|
|